Biomarkers of Cardiometabolic Risk, Inflammation and Disease

2015
ISBN: 978-3-319-16017-7
Verlag: Springer International Publishing

Buch, Englisch, 165 Seiten, HC runder Rücken kaschiert, Format (B × H): 160 mm x 241 mm, Gewicht: 4227 g

This book discusses recent advances in the area of cardiometabolic risk biomarkers of chronic inflammatory and cardiovascular disorders. Tackling the topic in a systematic manner, the book starts with an introduction to cardiometabolic risk and its clinical relevance, comparing emergent and classical biomarkers. It then goes on to discuss cardiometabolic risk biomarkers in a range of diseases, including diabetes, ischemic stroke and neurodegenerative disorders. 

Biomarkers of Cardiometabolic Risk, Inflammation and Disease is aimed at doctors specializing in internal medicine, neurology, cardiology, rheumatology, nephrology or endocrinology and will also be of interest to GPs, trainee doctors and clinical and basic researchers working on cardiovascular and autoimmune disorders.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Palavra, Filipe

Sena, Armando

Reis, Flávio

Marado, Daniela

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Endokrinologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Innere Medizin
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Diabetologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Kardiologie, Angiologie, Phlebologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Stoffwechselstörungen

Inhaltsverzeichnis

Inflammation biomarkers and cardiometabolic risk.- Cardiovascular disease.- Diabetes mellitus and metabolic syndrome.- Ischemic stroke.- Chronic kidney disease.- Immune-mediated inflammatory rheumatic diseases.- Cardiometabolic risk, inflammation and neurodegenerative disorders.

Über Autor(innen)

Filipe Palavra, MD

Laboratory of Pharmacology and Experimental Therapeutics

Institute for Biomedical Imaging and Life Sciences (IBILI)

Faculty of Medicine, Coimbra University

Coimbra, Portugal 

Flávio Reis, PhD

Laboratory of Pharmacology and Experimental Therapeutics

Institute for Biomedical Imaging and Life Sciences (IBILI)

Faculty of Medicine, Coimbra University

Coimbra, Portugal 

Daniela Marado, MD

Department of Internal Medicine – B

Centro Hospitalar e Universitário de Coimbra

Coimbra, Portugal

 Armando Sena, MD, PhD

Interdisciplinary Centre of Research Egas Moniz, CiiEM

Caparica, Portugal